# Dietary and lifestyle inflammation scores in relation to colon cancer recurrence in subgroups of patients based on common molecular tumour characteristics

**Authors:** E. Wesselink, D.E. Kok, K.C. Smit, A.-S. van Lanen, J.W.G. Derksen, M. Koopman, M. Ligtenberg, I.D. Nagtegaal, P.D.M. Rombout, J.H.W. de Wilt, E. Kampman, A.M. May, F.J.B. van Duijnhoven

PMC · DOI: 10.1016/j.esmogo.2025.100202 · ESMO Gastrointestinal Oncology · 2025-07-17

## TL;DR

This study found that a pro-inflammatory lifestyle, not diet, may increase colon cancer recurrence risk, especially in certain tumor types.

## Contribution

The study identifies how lifestyle inflammation affects recurrence risk in colon cancer subgroups based on tumor molecular features.

## Key findings

- A pro-inflammatory lifestyle was linked to higher recurrence risk in some tumor subgroups.
- The association was strongest in microsatellite stable and KRAS or PIK3CA wildtype tumors.
- Dietary inflammation was not significantly associated with recurrence.

## Abstract

The aim of this study was to investigate associations between the inflammatory potential of diet and lifestyle in relation to colon cancer recurrence in subgroups of patients based on molecular tumour characteristics that also influence the inflammatory tumour microenvironment.

A nested case-control study was implemented in two prospective cohort studies of colon cancer patients. Participants who developed a recurrence were included as cases (n = 167). Matched controls (n = 668) were selected based on incidence density sampling. Lifestyle factors were assessed at diagnosis using self-administered questionnaires and dietary intake was assessed using a food frequency questionnaire. The dietary inflammation score (DIS) and the lifestyle inflammation score (LIS) were constructed. High-throughput next-generation sequencing of tumour tissue was used for mutation and microsatellite instability (MSI) analysis. Associations between the DIS and LIS and recurrence were assessed with conditional logistic regression analyses in all patients, as well as in subgroups based on MSI. For patients with microsatellite stable (MSS) tumours, further stratification based on mutation status of KRAS, BRAF, PIK3CA, TP53 and APC was performed.

A more pro-inflammatory diet was not associated with risk of recurrence [incidence rate ratio (IRR) 1.04, 95% confidence interval (CI) 0.96-1.12]. Persons who have a more pro-inflammatory lifestyle may have an increased recurrence risk (IRR 1.21, 95% CI 0.97-1.52), which was most pronounced for persons with MSS and KRAS or PIK3CA wildtype tumours (IRR 1.31, 95% CI 0.90-1.90 and IRR 1.30, 95% CI 0.98-1.71, respectively).

Our results suggest that associations between the LIS and recurrence might differ based on molecular tumour characteristics.

Graphical abstract

•Our study suggests a pro-inflammatory lifestyle, but not diet, is linked to higher risk of colon cancer recurrence.•Associations seem to be most pronounced in microsatellite stable and KRAS or PIK3CA wildtype tumours.•Our study offers insights into which patients may benefit most from a less pro-inflammatory lifestyle after colon cancer.

Our study suggests a pro-inflammatory lifestyle, but not diet, is linked to higher risk of colon cancer recurrence.

Associations seem to be most pronounced in microsatellite stable and KRAS or PIK3CA wildtype tumours.

Our study offers insights into which patients may benefit most from a less pro-inflammatory lifestyle after colon cancer.

## Linked entities

- **Genes:** KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], TP53 (tumor protein p53) [NCBI Gene 7157], APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324], BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673]
- **Diseases:** colon cancer (MONDO:0002032)

## Full-text entities

- **Genes:** BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, KRAS (KRAS proto-oncogene, GTPase) [NCBI Gene 3845] {aka 'C-K-RAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}
- **Diseases:** microsatellite stable (MSS) tumours (MESH:D009369), colon cancer (MESH:D015179), dietary inflammation (MESH:D007249)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12836590/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12836590/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12836590/full.md

---
Source: https://tomesphere.com/paper/PMC12836590